Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Bill Salter, PhD

Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah

Bill J. Salter, PhD, DABR, FAAPM




Bill Salter, PhD, is a tenured Professor and Chief of the Division of Medical Physics, under the Department of Radiation Oncology, at the University of Utah’s School of Medicine. He is also Senior Director of Radiation Oncology at the Huntsman Cancer Institute and a Huntsman Cancer Institute Investigator.



Bill received his PhD in Medical Physics from the University of Texas Health Science Center at San Antonio, Texas in 1996.



Dr. Salter has served as a member of multiple AAPM Task Groups including TG66 CT Virtual Simulation, TG119 Intensity Modulated Radiation Therapy, TG154 Ultrasound Image Guidance and TG101 Stereotactic Body Radiation Therapy. He has served as an Examiner in Radiation Oncology Physics for the American Board of Radiology since 2010, is a member of the ASTRO RO-ILS Health Care Advisory Committee, the AAPM WG-RO-ILS, and is a Fellow of the AAPM. Dr. Salter implemented one of the first clinical Intensity Modulated Radiation Therapy programs in 1996, supervised the delivery of some of the first ever Intensity Modulated RadioSurgery treatments in 1998, implemented one of the first Stereotactic Body Radiation Therapy programs in 2000 and has most recently overseen the startup of Pencil Beam Scanning Proton Therapy at the University of Utah.

Disclosures:

  • Employment: Huntsman Cancer Institute at the University of Uta:Professor and Chief, Division of Medical Physics:Employee
  • Compensation: Clarity PSO/RO-ILS RO-HAC: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Honoraria-End Date: to present ;Mevion Medical System: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: to present ;American Society for Radiation Oncology (ASTRO):Role Topic Description-End Date: 07.12.2022 ;ASTRO:Role Topic Description-End Date: 10.26.2021 ;ASTRO, RO-HAC–/RO-ILS, ASRT Annual Meeting:Role Topic Description-End Date: 10.23.2022 ;Elekta Clarit: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;RaySearch Labs: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;University of Utah: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present
  • Ownership: none
  • Leadership: AAPM:Committee Member;ACR:Committee Member;ASTRO:Committee Member;University of Utah:Committee co-leader;Varian, a Siemens Healthineers company:Committee Member

Presentation(s):